Hassenfeld Children’s Hospital at NYU Langone: A leader in pediatric cardiology and heart surgery care

The FDA has ap­proved the first over-the-counter birth con­trol pill, Per­ri­go’s Opill, clear­ing the way for con­sumers to eas­i­ly ac­cess the con­tra­cep­tive at drug stores,

Adap­tive Biotech­nolo­gies, a Seat­tle-based di­ag­nos­tics mak­er and drug dis­cov­ery com­pa­ny, told End­points News it re­cent­ly elim­i­nat­ed 6.7% of its work­force as part of its strate­gic